news

Nov 21 2017
TapImmune to Present at 29th Annual Piper Jaffray Healthcare Conference

Nov 20 2017
Promentis Pharmaceuticals Commences Phase 1 Study for SXC-2023 Targeting Neuropsychiatric Disorders

Nov 16 2017
KemPharm Completes Successful End-of-Phase 2 Meeting on KP415 with FDA


 

events

Nov 27-29 2017
European Microbiome Congress

Nov 28-29 2017
Piper Jaffray Healthcare Conference

Dec 9-12 2017
59th ASH Annual Meeting and Exposition

Jan 8-11 2018
JP Morgan Healthcare Conference


 

spotlight